Mesenchymal chondrosarcoma with secondary orbital invasion.
Orbital involvement with mesenchymal chondrosarcoma is rare. Until recently, despite the young age of the affected population, exenteration was the recommended management. We report a patient with orbital invasion by mesenchymal chondrosarcoma managed surgically without exenteration. Adjuvant chemotherapy and radiotherapy were administered. There is no evidence of local or distant tumor recurrence with 30 months of postoperative follow-up. This and other recent case reports suggest that exenteration may not be necessary for local tumor control of mesenchymal chondrosarcoma in the orbit.
Lauer
S A
SA
Department of Ophthalmology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York, USA.
Friedland
S
S
Goodrich
J T
JT
Dorfman
H
H
D000293:Adolescent; D001859:Bone Neoplasms / Q000473:pathology* / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D018211:Chondrosarcoma, Mesenchymal / Q000473:pathology / Q000556:secondary* / Q000628:therapy; D005005:Ethmoid Sinus / Q000473:pathology; D006801:Humans; D008297:Male; D009918:Orbital Neoplasms / Q000556:secondary* / Q000628:therapy; D010255:Paranasal Sinus Neoplasms / Q000473:pathology; D018714:Radiotherapy, Adjuvant; D014057:Tomography, X-Ray Computed